MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Rethinking Parking Lot Design at Irvine Heritage Medical Plaza
A new solar installation shows how healthcare facilities can improve parking amenities while boosting energy savings
Repurposing Healthcare Spaces: 5 Critical Questions
Done well, converting existing spaces can trim upfront project costs by up to 40 percent, compared with ground-up construction
Disinfectant Contact Time: The Case for Biofilm Disruption
Contact time, while essential for compliance, does not reliably predict microbial reduction on actual healthcare surfaces.
Rethinking How Healthcare Facilities Fund Construction Projects
Rising costs and competing priorities are driving healthcare organizations to explore new financing arrangements and construction strategies.